300 related articles for article (PubMed ID: 31251393)
1. Survival disparities for second primary malignancies diagnosed among childhood cancer survivors: A population-based assessment.
Brown AL; Arroyo VM; Agrusa JE; Scheurer ME; Gramatges MM; Lupo PJ
Cancer; 2019 Oct; 125(20):3623-3630. PubMed ID: 31251393
[TBL] [Abstract][Full Text] [Related]
2. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors.
Keegan THM; Bleyer A; Rosenberg AS; Li Q; Goldfarb M
JAMA Oncol; 2017 Nov; 3(11):1554-1557. PubMed ID: 28426850
[TBL] [Abstract][Full Text] [Related]
3. Risk and subtypes of secondary primary malignancies in diffuse large B-cell lymphoma survivors change over time based on stage at diagnosis.
Major A; Smith DE; Ghosh D; Rabinovitch R; Kamdar M
Cancer; 2020 Jan; 126(1):189-201. PubMed ID: 31509235
[TBL] [Abstract][Full Text] [Related]
4. Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study.
Henderson TO; Whitton J; Stovall M; Mertens AC; Mitby P; Friedman D; Strong LC; Hammond S; Neglia JP; Meadows AT; Robison L; Diller L
J Natl Cancer Inst; 2007 Feb; 99(4):300-8. PubMed ID: 17312307
[TBL] [Abstract][Full Text] [Related]
5. Impact of latency time on survival for adolescents and young adults with a second primary malignancy.
Goldfarb M; Rosenberg AS; Li Q; Keegan THM
Cancer; 2018 Mar; 124(6):1260-1268. PubMed ID: 29205296
[TBL] [Abstract][Full Text] [Related]
6. Increased incidence of second primary malignancy in patients with malignant astrocytoma: a population-based study.
Wang W
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138756
[TBL] [Abstract][Full Text] [Related]
7. Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report.
Goldsby RE; Stratton KL; Raber S; Ablin A; Strong LC; Oeffinger K; Sklar CA; Armstrong GT; Robison LL; Bhatia S; Leisenring WM
Cancer; 2018 Feb; 124(3):617-625. PubMed ID: 29105081
[TBL] [Abstract][Full Text] [Related]
8. Racial Differences in 20-Year Cardiovascular Mortality Risk Among Childhood and Young Adult Cancer Survivors.
Berkman AM; Brewster AM; Jones LW; Yu J; Lee JJ; Peng SA; Crocker A; Ater JL; Gilchrist SC
J Adolesc Young Adult Oncol; 2017 Sep; 6(3):414-421. PubMed ID: 28530506
[TBL] [Abstract][Full Text] [Related]
9. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
10. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
Vakharia PP; Kelm RC; Orrell KA; Patel KR; Singam V; Ali Y; Rastogi S; Yousif R; Rangel SM; West DP; Nardone B
Int J Dermatol; 2020 Apr; 59(4):463-468. PubMed ID: 31971260
[TBL] [Abstract][Full Text] [Related]
11. Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States.
Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
Int J Cancer; 2019 Jul; 145(1):143-153. PubMed ID: 30613963
[TBL] [Abstract][Full Text] [Related]
12. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.
Gibson TM; Mostoufi-Moab S; Stratton KL; Leisenring WM; Barnea D; Chow EJ; Donaldson SS; Howell RM; Hudson MM; Mahajan A; Nathan PC; Ness KK; Sklar CA; Tonorezos ES; Weldon CB; Wells EM; Yasui Y; Armstrong GT; Robison LL; Oeffinger KC
Lancet Oncol; 2018 Dec; 19(12):1590-1601. PubMed ID: 30416076
[TBL] [Abstract][Full Text] [Related]
13. Secondary bone/soft tissue sarcoma in childhood cancer survivors: a nationwide hospital-based case-series study in Japan.
Ishida Y; Maeda M; Adachi S; Rikiishi T; Sato M; Kawaguchi H; Manabe A; Tokuyama M; Hori H; Okamura J; Ogawa A; Goto H; Kobayashi R; Yoshinaga S; Fujimoto J; Kuroda T
Jpn J Clin Oncol; 2018 Sep; 48(9):806-814. PubMed ID: 30053029
[TBL] [Abstract][Full Text] [Related]
14. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.
Bu X; Wang X; Wei L; Liu J; Chen M
Curr Probl Cancer; 2020 Dec; 44(6):100613. PubMed ID: 32563531
[TBL] [Abstract][Full Text] [Related]
15. The risk of developing second cancers among survivors of childhood soft tissue sarcoma.
Cohen RJ; Curtis RE; Inskip PD; Fraumeni JF
Cancer; 2005 Jun; 103(11):2391-6. PubMed ID: 15852362
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
[TBL] [Abstract][Full Text] [Related]
17. Risk of second primary malignancies in survivors of pancreatic neuroendocrine neoplasms from 2000 to 2018.
Yang Z; Liu L; Leng K; Shi G
J Gastroenterol Hepatol; 2023 Sep; 38(9):1474-1484. PubMed ID: 37114675
[TBL] [Abstract][Full Text] [Related]
18. Influence factors of the survival in colorectal cancer patients with second primary malignancy after surgery: A SEER database analysis.
Liu L; Chen B
Medicine (Baltimore); 2023 Oct; 102(40):e35286. PubMed ID: 37800769
[TBL] [Abstract][Full Text] [Related]
19. Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt.
Sedeta E; Jemal A; Nisotel L; Sung H
Cancer; 2024 Jun; 130(11):1952-1963. PubMed ID: 38244208
[TBL] [Abstract][Full Text] [Related]
20. Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study.
Suh E; Stratton KL; Leisenring WM; Nathan PC; Ford JS; Freyer DR; McNeer JL; Stock W; Stovall M; Krull KR; Sklar CA; Neglia JP; Armstrong GT; Oeffinger KC; Robison LL; Henderson TO
Lancet Oncol; 2020 Mar; 21(3):421-435. PubMed ID: 32066543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
